Search
Scientists at J. Craig Venter Institute, Scripps Institution of Oceanography and Other Collaborators, Publish Paper Outlining New View of Microbial Relationships in Southern Ocean Phytoplankton Blooms
(La Jolla, CA)—July 28, 2015—A team of ocean researchers led by those at the J. Craig Venter Institute (JCVI) and Scripps Institution of Oceanography (SIO) have uncovered a series of complicated relationships among marine microbes and their fight for important resources such as iron, light and Vitamin B12. These relationships appear to have critical consequences for coastal Southern Ocean food webs. JCVI and SIO, along with those at the University of Southern California (USC), and the...
Scientists at the J. Craig Venter Institute Publish Paper Outlining Efficient Synthetic Biology Methods to Genetically Engineer Microalgae
LA JOLLA, CA – April 21, 2015 – Scientists from the J. Craig Venter Institute (JCVI), a not-for-profit genomic research organization, published a paper today outlining new synthetic biology methods to manipulate a type of microalgae called diatoms. The researchers, led by first author Bogumil Karas, Ph.D. and senior author Philip Weyman, Ph.D., conclude that these new and efficient methods will enable better understanding of diatom genetics and thus facilitate advances in engineering these...
Dr. J. Craig Venter wins the Leeuwenhoek Medal
De Leeuwenhoek Medal 2015 has been awarded to Dr. J. Craig Venter. The medal was presented to him by the Dutch State Secretary of Education, Culture and Science Sander Dekker at the annual conference of the Royal Netherlands Society for Microbiology (KNVM) and The Netherlands Society for Medical Microbiology (NVMM) April 14 at Papendal, Arnhem. The Leeuwenhoek-medal is the most prestigious prize in the field of Microbiology. It has been awarded every 10 years since 1877 to a scientist who...
J. Craig Venter Institute Key Member of Team Awarded up to a 5-Year, $23 Million Contract from National Institute of Allergy and Infectious Diseases for Renewal of Bioinformatics Resource Centers for Infectious Diseases Viral Project
ROCKVILLE, MD and LA JOLLA, CA – November 11, 2014 – Scientists from the J. Craig Venter Institute (JCVI), a not-for-profit genomic research organization, are key members of a team recently awarded up to a 5-year, $23 million contract by the National Institute of Allergy and Infectious Diseases (NIAID) for the Bioinformatics Resource Centers (BRC) for Infectious Diseases Viral Project. The JCVI-Northrop Grumman Systems Corporation-Vecna Team continues as lead organizations on this...
J. Craig Venter Institute Hires Nicole DeBerg as Chief Operating Officer
LA JOLLA, CA (September 9, 2014)—The J. Craig Venter Institute (JCVI), a not-for-profit genomic research organization, announced today they have hired Nicole DeBerg as Chief Operating Officer (COO). DeBerg is based in the JCVI La Jolla, California facility and reports to J. Craig Venter, Ph.D., Founder, Chairman and CEO for JCVI and Karen Nelson, Ph.D., JCVI President. She will be responsible for a variety of operational functions at JCVI including finance and sponsored projects. A...
J. Craig Venter Institute Awarded 5 year, approximately $25 Million NIH Grant to Establish a Genome Center for Infectious Diseases
ROCKVILLE, MD and LA JOLLA, CA—June 5, 2014—Scientists from the J. Craig Venter Institute (JCVI), a not-for-profit genomic research organization, have been awarded a five year grant from the NIH’s National Institute of Allergy and Infectious Diseases (NIAID) to establish and operate a Genome Center for Infectious Diseases (GCID). Funding for this Center is up to $25 million over the 5 year award period. The goal of the grant is to further develop and enhance basic science understanding of...
Venter Institute-Led Policy Group Publishes Report on Challenges and Options for Oversight of Organisms Engineered Using Synthetic Biology Technologies
ROCKVILLE, MD and SAN DIEGO, CA—May 28, 2014—Policy researchers from the J. Craig Venter Institute (JCVI), the University of Virginia, and EMBO today released a report detailing the challenges faced by regulators with the increased use of more sophisticated synthetic biology technologies to engineer plants and microbes and some options for dealing with these challenges. The authors conclude that while the United States governmental agencies tasked with oversight of products derived...
Human Longevity Inc. (HLI) Launched to Promote Healthy Aging Using Advances in Genomics and Stem Cell Therapies
SAN DIEGO, March 4, 2014 — Human Longevity Inc. (HLI), a genomics and cell therapy-based diagnostic and therapeutic company focused on extending the healthy, high performance human life span, was announced today by co-founders J. Craig Venter, Ph.D., Robert Hariri, M.D., Ph.D., and Peter H. Diamandis, M.D. The company, headquartered in San Diego, California, is being capitalized with an initial $70 million in investor funding. HLI's funding is being used to build the largest human...